Dow Up 0.72% Nasdaq Up 1.84%

Acceleron Pharma, Inc. (XLRN)

-NasdaqGM
25.50 Up 0.87(3.53%) 10:20AM EST - Nasdaq Real Time Price
Prev Close:24.63
Open:24.83
Bid:25.61 x 100
Ask:25.73 x 100
1y Target Est:56.25
Beta:N/A
Earnings Date:Feb 29 - Mar 4 (Est.)
Day's Range:24.37 - 26.50
52wk Range:20.00 - 50.86
Volume:28,553
Avg Vol (3m):424,624
Market Cap:945.65M
P/E (ttm):N/A
EPS (ttm):-1.57
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XLRNUp 3.53%945.65M
AMGNUp 1.53%109.59B
JNJUp 0.43%283.36B
BLUEUp 0.59%1.69B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):45.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.18
Quarterly EPS Est (Dec-15) :-0.09
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback